NTLA - Inverse head & shoulders

Panjang

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Telah dikemas kini

NASDAQ:NTLA Intellia Therapeutics, Inc.

trendanalysis headandshoulders crispr biotech head shoulders pattern bio tech

An inverse head & shoulders pattern formed in the charts of Intellia, a company developing CRISPR gene-editing therapy. While CRISPR has not been approved to begin human trials in the US, it has already been tested on over 80 patients in China.

Target: $31 (previous closing high), or long term hold
Stop: $18 - $20

Komen:

Note: 2 other companies also developing CRISPR-Cas9 tech are CRSP and EDIT. Their stocks have skyrocketed the past month. It is advisable to wait for a correction before taking a position on them.

Dagangan ditutup: sasaran tercapai:

It wasn't a straightforward journey, but got there on time anyway! I hope everyone reading took profits at $31 (or even higher)

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.